NIN JIOM PEI PA KOA

Manufacturer: NIN JIOM MEDICINE MANUFACTORY (HK) LTD
Effective date: 2011-03-10
Label type: HUMAN OTC DRUG LABEL
Version: 11
Source: full-release
Hydrated at: 2026-05-31 22:27:27

Label at a glance#

ProductNIN JIOM PEI PA KOA

Active ingredientELM

Label structure9 sections

Dosage and administration

Adults and Children 2 years of age and older: 2 teaspoonfuls every 2 hours as needed or as directed by a doctor or dentist. Children under 2 years of age: Consult a doctor or dentist.

Label contents#

Full prescribing information#

DESCRIPTION SECTION

King to Nin Jiom Pei Pa Koa is a pleasant tasting natural herbal based liquid especially formulated for relief of minor discomfort and to protect irritated areas in sore mouth and sore throat.

Pei Pa Koa contains No Alcohol, artificial flavors, colors, or preservatives.

INDICATIONS

INDICATIONS & USAGE SECTION

For the temporary relief of minor discomfort and protection of irritated areas in sore mouth and sore throat.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

Adults and Children 2 years of age and older: 2 teaspoonfuls every 2 hours as needed or as directed by a doctor or dentist.
Children under 2 years of age: Consult a doctor or dentist.

WARNINGS

WARNINGS SECTION

If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting consult a doctor promptly. If sore mouth symptoms do not improve in 7 days, see your dentist or doctor promptly. If you are pregnant or nursing a baby seek the advice of a health professional before using this product. Keep this and all drugs out of the reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all drugs out of the reach of children.

Active:

OTC - ACTIVE INGREDIENT SECTION

Elm Bark 650 mg per teaspoon.

In a Sucrose Syrup and Honey base of herbal extracts consisting of:

INACTIVE INGREDIENT SECTION

loquat leaf, fritillary, balloon flower root, snakegourd seed, sand root, senega root, tuckahoe, licorice root, ginger root, five flavored seed, and peppermint.

OTC - PURPOSE SECTION

For the temporary relief of minor discomfort and protection of irritated areas in sore mouth and sore throat.

Product Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PPKLabel

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
57708-888-02	2019-10-29	C162847	48780-1	960f7f55-d5a4-8e05-e053-dbdaa90a074a	Product Facts
57708-888-04	2019-10-29	C162847	48780-1	960f7f55-d5a4-8e05-e053-dbdaa90a074a	Product Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
57708-888-01	NIN JIOM PEI PA KOA	300 mL in 1 BOTTLE, GLASS	SYRUP	300	11
57708-888-02	NIN JIOM PEI PA KOA	24 in 1 CARTON	SYRUP	24	11
57708-888-03	NIN JIOM PEI PA KOA	150 mL in 1 BOTTLE, GLASS	SYRUP	150	11
57708-888-04	NIN JIOM PEI PA KOA	48 in 1 CARTON	SYRUP	48	11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
57708-888	NIN JIOM PEI PA KOA (ELM BARK) SYRUP [NIN JIOM MEDICINE MANUFACTORY (HK) LTD]	11	Legacy NDC, 4 package rows	20110315_ad386748-3cbe-4d2f-972d-2ccf1b04aaac.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ELM	ACTIVE INGREDIENT	63POE2M46Y	11
ELM	ACTIVE MOIETY	63POE2M46Y	11
ERIOBOTRYA JAPONICA LEAF	INACTIVE INGREDIENT	Z02066SV11	11
FRITILLARIA PRZEWALSKII BULB	INACTIVE INGREDIENT	8B269H8XVH	11
FU LING	INACTIVE INGREDIENT	XH37TWY5O4	11
GINGER	INACTIVE INGREDIENT	C5529G5JPQ	11
GLEHNIA LITTORALIS ROOT	INACTIVE INGREDIENT	75447U56MI	11
GREATER GALANGAL	INACTIVE INGREDIENT	7Y64R856MB	11
HONEY	INACTIVE INGREDIENT	Y9H1V576FH	11
LICORICE	INACTIVE INGREDIENT	61ZBX54883	11
PEPPERMINT	INACTIVE INGREDIENT	V95R5KMY2B	11
PLATYCODON GRANDIFLORUM LEAF	INACTIVE INGREDIENT	2L64H2X8DY	11
POLYGALA SENEGA ROOT	INACTIVE INGREDIENT	M7T6H7D4IF	11
SCHISANDRA CHINENSIS FRUIT	INACTIVE INGREDIENT	ABS794681C	11
SUCROSE	INACTIVE INGREDIENT	C151H8M554	11
TRICHOSANTHES CUCUMERINA SEED	INACTIVE INGREDIENT	O6375G869C	11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NIN JIOM PEI PA KOA
ELM BARK
ELM
SUCROSE
PLATYCODON GRANDIFLORUM LEAF
FRITILLARIA PRZEWALSKII BULB
ERIOBOTRYA JAPONICA LEAF
GLEHNIA LITTORALIS ROOT
HONEY
POLYGALA SENEGA ROOT
GREATER GALANGAL
LICORICE
GINGER
PEPPERMINT
FU LING
SCHISANDRA CHINENSIS FRUIT
TRICHOSANTHES CUCUMERINA SEED

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
57708-888	57708-888-01, 57708-888-02, 57708-888-03, 57708-888-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ELM	63POE2M46Y	ACTIB
SUCROSE	C151H8M554	IACT
PLATYCODON GRANDIFLORUM LEAF	2L64H2X8DY	IACT
FRITILLARIA PRZEWALSKII BULB	8B269H8XVH	IACT
ERIOBOTRYA JAPONICA LEAF	Z02066SV11	IACT
GLEHNIA LITTORALIS ROOT	75447U56MI	IACT
HONEY	Y9H1V576FH	IACT
POLYGALA SENEGA ROOT	M7T6H7D4IF	IACT
GREATER GALANGAL	7Y64R856MB	IACT
LICORICE	61ZBX54883	IACT
GINGER	C5529G5JPQ	IACT
PEPPERMINT	V95R5KMY2B	IACT
FU LING	XH37TWY5O4	IACT
SCHISANDRA CHINENSIS FRUIT	ABS794681C	IACT
TRICHOSANTHES CUCUMERINA SEED	O6375G869C	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 50 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
GINGER	GINGER	C5529G5JPQ	ELIXIR / ORAL	10 mg/5ml		Exact identifier — unii candidate 2 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
GINGER	GINGER	C5529G5JPQ	SYRUP / ORAL	0.05 ml/5ml		Exact identifier — unii candidate 2 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
b7674537-bbbf-48e5-bdfd-54dd4f520afd			ad386748-3cbe-4d2f-972d-2ccf1b04aaac	2011-03-10	Warnings	Exact identifier spl id: b7674537-bbbf-48e5-bdfd-54dd4f520afd spl set id: ad386748-3cbe-4d2f-972d-2ccf1b04aaac

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.